This panel brings together leading researchers to explore how health economics can inform policy design in the context of the ...

In this report, we explore the status of access and uptake for NGS testing for lung cancer in Europe, develop the health economic case for NGS testing, and identify barriers and opportunities for ...

Our research provides an update on the trajectory of dementia and highlights the significant effects of dementia research on the UK economy. We estimate that: in 2040, over 1.2 million people in the ...

This webinar shared the topics on which OHE research had the biggest impact in 2024 including drug shortages and vaccines, whilst looking ahead to 2025.

After the shock caused by the first wave of COVID-19, discovering vaccines against the virus and administering them quickly to the population became the utmost priority worldwide, especially once ...

Real-World Evidence (RWE) can provide decision-makers in the healthcare sector with insights into the functioning of health technologies outside of clinical trial settings. In this report, we focus on ...

The purpose of this research is to identify the attributes to include in a value framework for orphan medicinal products (OMPs), determine their relative importance using a multi-criteria decision ...

In 2015, OHE published a report which set out the core principles that should govern how Real-World Data (RWD) is accessed or generated, and used credibly to generate Real-World Evidence (RWE), ...

The US spends significantly more on healthcare per person than other wealthy countries. H.R. 3 is a recent policy proposal aimed at reducing national spending on prescription drugs, one component of ...

The OHE Annual Lecture is our opportunity to highlight urgent and important issues facing health systems around the world. OHE’s educational mission is to support, sustain, and enhance the discipline ...

OHE Research Paper 19/02: The combination of rising drug costs in the US and increasing financial stress for individual patients has triggered intense national concern. One target has come under ...